Cortexin
Polypeptide complex derived from porcine cerebral cortex — approved in Russia for stroke, TBI, epilepsy, and cognitive disorders. Contains a mixture of neuropeptides, amino acids, and microelements.
🔬 Mechanism of Action
Cortexin is a complex polypeptide preparation derived from the cerebral cortex of cattle or pigs, containing a cocktail of low-molecular-weight neuropeptides (molecular weight <10 kDa), amino acids, vitamins, and trace minerals. Developed in Russia and approved since 1999 for neurological conditions.
Its multi-component nature means it acts through several simultaneous mechanisms: (1) BDNF-like neurotrophic support for neuronal survival, (2) GABA/glutamate balance modulation (reducing excitotoxicity), (3) antioxidant protection of neuronal membranes via trace mineral cofactors, and (4) facilitation of interhemispheric connectivity and synaptic transmission.
Clinical trials in Russia have shown significant benefits in: acute stroke (43% improvement in NIHSS scores), TBI recovery (accelerated cognitive and motor recovery), and epilepsy (25-30% seizure frequency reduction as adjunct therapy).
Source: PMID: 17436040
📜Background & History
Cortexin was developed at the S.M. Kirov Military Medical Academy in St. Petersburg, Russia, and approved for medical use since 1999. It is one of the most widely prescribed neuropeptide preparations in Russia — used across the spectrum from pediatric neurodevelopmental delay to adult stroke recovery to geriatric cognitive decline. The preparation is a complex mixture of low-molecular-weight polypeptides (<10 kDa) extracted from bovine or porcine cerebral cortex, combined with amino acids, vitamins, and trace minerals. Over 100,000 patients have been treated in Russian clinical practice.
🎯 Research Use Cases
- ✓Stroke rehabilitation (acute and chronic phase)
- ✓Traumatic brain injury recovery
- ✓Age-related cognitive impairment
- ✓Pediatric neurodevelopmental support
- ✓Epilepsy adjunct therapy
💉 Dosing Protocol
| Typical Dose | 5-10 mg/day IM |
| Frequency | 1× daily for 10-20 days |
| Half-Life | ~30-60 minutes (estimated) |
| Common Vial Sizes | 5 mg, 10 mg |
🧪 Reconstitution Example
⚠️Safety & Considerations
Approved in Russia since 1999 with extensive clinical use. Intramuscular injection is the standard route. Animal-derived preparation — potential allergenic risk in sensitive individuals. No significant drug interactions documented. Local injection site reactions are the most common side effect.
⚡Interactions & Contraindications
Animal-derived preparation — potential allergenic risk. IM injection route only. No significant drug interactions documented in Russian clinical data. Can be combined with standard neurological medications.
🔗Synergies & Common Stacks
Cortexin provides broad neuroprotection and membrane stabilization while P21 specifically drives hippocampal neurogenesis — complementary neuroprotective approaches for cognitive decline.
Cortexin (complex neuropeptide preparation, IM injection) + Semax (targeted ACTH fragment, intranasal) provide multi-pathway CNS support through different mechanisms and routes.